$27, $17, $7...well at least we are running out
of room on the downside. I was so pleased that I
avoided the first ten dollar loss, but the rest of
the fall certainly hurt. Since I am long 9k shares,
having doubled up as we broke below $10, I am sure
longing for the $teens again.
One of the interesting claims we have heard from Tgen,
is their leadership in producing high titer, wild type
free AAV (sorry if my jargon is not correct, it is
something like that). Here is a fairly recent abstract
--is everybody else out there catching up? Does Tgen
have any patents in this area? Is the London system
similar?
J Virol Methods 2000 Mar;85(1-2):23-34
A method for the preparation of highly purified adeno-
associated virus using affinity column chromatography,
protease digestion and solvent extraction.
Anderson R, Macdonald I, Corbett T, Whiteway A,
Prentice HG
Department of Haematology, Royal Free and University
College Medical School of University College London
PMID: 10716335, UI: 20179079
ncbi.nlm.nih.gov |
